- Home>
- Journal Watch
- >
- rheumatoid arthritis
Search for rheumatoid arthritis in all Journal Watch editions
Physician-authored summaries on the latest research on rheumatoid arthritis, editorials on rheumatoid arthritis, and perspectives on rheumatoid arthritis - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 313 results - Relevance
- Date
You searched for: rheumatoid arthritis
-
Rheumatoid Arthritis Linked to Risks for Atrial Fibrillation and Stroke Free
- March 22, 2012
- Paul S. Mueller, MD, MPH, FACP
- General Medicine
Close monitoring of RA patients is warranted.- Reviewing:
- Lindhardsen J et al., BMJ 2012 Mar 8; 344:e1257.
-
Should Prednisone Be Added to Methotrexate for Early Rheumatoid Arthritis?
- March 22, 2012
- Jamaluddin Moloo, MD, MPH
- General Medicine
Yes, according to a randomized trial — but with caveats.- Reviewing:
- Bakker MF et al., Ann Intern Med 2012 Mar 6; 156:329.
-
TNF Inhibitors Double Infection Risk Free
- July 28, 2011
- Allan S. Brett, MD
- General Medicine
At 1 year, tumor necrosis factor inhibitors were associated with excess risk for serious infections in rheumatoid arthritis patients.
CME Exam- Reviewing:
- Komano Y et al., J Rheumatol 2011 Jul; 38:1258.
-
Patients Taking Disease-Modifying Antirheumatic Drugs Also Developed Less New Diabetes
- July 15, 2011
- Jeffrey P. Callen, MD
- Dermatology
Decreased incidence was associated with TNF antagonists and hydroxychloroquine but not with methotrexate.
CME Exam- Reviewing:
- Solomon DH et al., JAMA 2011 Jun 22/29; 305:2525. Bongartz T and Kudva Y., JAMA 2011 Jun 22/29; 305:2573.
-
New Classification Criteria for Rheumatoid Arthritis
- September 23, 2010
- Allan S. Brett, MD
- General Medicine
The goal is early identification of patients who can benefit from intervention.
CME Exam- Reviewing:
- Aletaha D et al., Arthritis Rheum 2010 Sep; 62:2569.
-
Drug-Induced Dermatomyositis Due to Tumor Necrosis Factor Antagonists
- August 27, 2010
- Jeffrey P. Callen, MD
- Dermatology
TNF inhibitors are valuable against inflammatory disease, but reports link their use to dermatomyositis in some patients.- Reviewing:
- Klein R et al., Arch Dermatol 2010 Jul; 146:780. Brunasso AMG et al., J Rheumatol 2010 Jul; 37:1549.
-
Is the Incidence and Prevalence of Rheumatoid Arthritis Rising Among Women?
- August 17, 2010
- Jonathan S. Coblyn, MD
- General Medicine
Smoking, vitamin D deficiency, and low-estrogen-dose oral contraceptives could be factors.
CME Exam- Reviewing:
- Myasoedova E et al., Arthritis Rheum 2010 Jun; 62:1576.
-
Global Gastrointestinal Events with Celecoxib vs. Diclofenac and Omeprazole
Risks for clinical events throughout the GI tract were lower with a cyclooxygenase-2 inhibitor than with a nonselective nonsteroidal anti-inflammatory drug plus a proton-pump inhibitor.- Reviewing:
- Chan FKL et al., Lancet 2010 Jun 17;: Rahme E and Bernatsky S., Lancet 2010 Jun 17;:
-
Infliximab Is Superior to Conventional DMARDs in Patients with Early RA
- August 13, 2009
- Bruce Soloway, MD
- General Medicine
Adding a TNF antagonist to methotrexate resulted in a significantly better response to therapy.- Reviewing:
- van Vollenhoven RF et al., Lancet 2009 Aug 8; 374:459.
-
Herpes Zoster in Arthritis Patients Who Take Anti-TNF-α Agents
- March 10, 2009
- Thomas L. Schwenk, MD
- General Medicine
- Reviewing:
- Strangfeld A et al., JAMA 2009 Feb 18; 301:737. Whitley RJ and Gnann JW Jr., JAMA 2009 Feb 18; 301:774.
-
Herpes Zoster and TNF-α Antagonists Free
- March 4, 2009
- Richard T. Ellison III, MD
- Infectious Diseases
Rheumatoid arthritis patients treated with infliximab or adalimumab are at increased risk for herpes zoster.- Reviewing:
- Strangfeld A et al., JAMA 2009 Feb 18; 301:737. Whitley RJ and Gnann JW Jr., JAMA 2009 Feb 18; 301:774.
-
Risk for Herpes Zoster with Anti–TNF-α Agents
- February 27, 2009
- Jan V. Hirschmann, MD
- Dermatology
Herpes zoster may occur more often and more severely in patients receiving monoclonal antibody treatment.- Reviewing:
- Strangfeld A et al., JAMA 2009 Feb 18; 301:737.
-
TNF Antagonists for Treatment of Juvenile Rheumatoid Arthritis
- September 25, 2008
- Deborah M. DeMarco, MD
- General Medicine
In children, adalimumab with or without methotrexate reduced disease activity and number of flares.- Reviewing:
- Lovell DJ et al., N Engl J Med 2008 Aug 21; 359:810.
-
Methotrexate plus Etanercept for Early, Moderate-to-Severe RA
- August 12, 2008
- Thomas L. Schwenk, MD
- General Medicine
Likelihood of remission and of radiographic nonprogression was greater with combination therapy than with methotrexate alone.- Reviewing:
- Emery P et al., Lancet 2008 Aug 2; 372:375. Kremer JM., Lancet 2008 Aug 2; 372:347.
-
Is Congestive Heart Failure Triggered or Treated by Inhibition of TNF?
- June 24, 2008
- Deborah M. DeMarco, MD
- General Medicine
Patients with severe rheumatoid arthritis, especially those with highly active disease, are at high risk for development or worsening of heart failure.- Reviewing:
- Listing J et al., Arthritis Rheum 2008 Mar; 58:667.
-
Tocilizumab: Interleukin-6 Inhibitor Is Effective in Adult and Juvenile Arthritis
- March 27, 2008
- Bruce Soloway, MD
- General Medicine
Its potential seems greatest as a treatment for juvenile idiopathic arthritis.- Reviewing:
- Smolen JS et al., Lancet 2008 Mar 22; 371:987. Yokota S et al., Lancet 2008 Mar 22; 371:998. Bongartz T., Lancet 2008 Mar 22; 371:961.
-
Bedtime Dose of Modified-Release Prednisone Reduces Morning Arthritis Stiffness
- February 7, 2008
- Bruce Soloway, MD, and Allan S. Brett, MD
- General Medicine
Modified-release prednisone offered greater relief of morning stiffness and no greater risk than immediate-release prednisone.- Reviewing:
- Buttgereit F et al., Lancet 2008 Jan 19; 371:205.
-
Biologic Therapies Appear to Increase Skin Cancer Risk in Rheumatoid Arthritis Patients
- November 30, 2007
- Jeffrey P. Callen, MD
- Dermatology
RA patients receiving these agents had higher rates of nonmelanoma skin cancer and melanoma.- Reviewing:
- Wolfe F and Michaud K., Arthritis Rheum 2007 Sep; 56:2886.
-
TNF Antagonists and Risk for Bacterial Infection
- April 10, 2007
- Allan S. Brett, MD
- General Medicine
Patients taking TNF antagonists had significantly higher risk than those taking methotrexate alone.- Reviewing:
- Curtis JR et al., Arthritis Rheum 2007 Apr; 56:1125-33.
-
Can We Safely and Effectively Immunize Patients Receiving Anti-TNF Therapies? Free
- March 9, 2007
- Jeffrey P. Callen, MD
- Dermatology
Results in rheumatoid arthritis patients demonstrate some benefit from flu and pneumococcal vaccination in patients receiving biologic therapy.- Reviewing:
- Kaine JL et al., J Rheumatol 2007 Feb; 34:272-9.
Sort by:
Items 1 to 20 of 313 results - Relevance
- Date
